Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMOX1 | P09601 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.33 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21509221 | 0.79 | TAAR1 (0.42) | HMOX1TAAR1HTR2AOPRM1OPRD1 | |
| SCHEMBL6436895 | 0.75 | TAAR1 (0.39) | HMOX1TAAR1HTR2AOPRM1OPRD1 | |
| SCHEMBL1376365 | 0.74 | TAAR1 (0.45) | HMOX1TAAR1HTR2AOPRM1OPRD1 | |
| SCHEMBL12126621 | 0.74 | HMOX1 (0.47) | HMOX1TAAR1HTR2AOPRM1OPRD1 | |
| SCHEMBL13535442 | 0.72 | HMOX1 (0.37) | HMOX1TAAR1HTR2AOPRM1OPRD1 | |
| SCHEMBL12144581 | 0.69 | KDM1A (0.48) | HMOX1TAAR1HTR2AOPRM1OPRD1 | |
| SCHEMBL23714748 | 0.68 | TAAR1 (0.39) | HMOX1TAAR1HTR2AOPRM1OPRD1 | |
| SCHEMBL20512444 | 0.67 | OPRM1 (0.60) | HMOX1TAAR1HTR2AOPRM1OPRD1 | |
| SCHEMBL589201 | 0.66 | POLB (0.38) | HMOX1TAAR1POLBCTDSP1 | |
| SCHEMBL626076 | 0.63 | TAAR1 (0.68) | TAAR1HTR2APOLBCTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9051277-B2 | Phenyl(oxy/thio)alkanol derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-06-09 | — | — | US | claimed |
| US-20140357649-A1 | Phenyl(oxy/thio)alkanol Derivatives | BAYER CROPSCIENCE AG (DE) | 2014-12-04 | — | — | US | claimed |
| EP-2451784-A1 | PHENYL(OXY/THIO)ALKANOL DERIVATIVES | Bayer CropScience AG (DE) | 2012-05-16 | — | — | EP | claimed |
| US-20110039865-A1 | Phenyl(oxy/thio)alkanol Derivatives | BAYER CROPSCIENCE AG (DE) | 2011-02-17 | — | — | US | claimed |
| WO-2011003527-A1 | PHENYL(OXY/THIO)ALKANOL DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2011-01-13 | — | — | WO | claimed |
| US-9321732-B2 | Phenyl(oxy/thio)alkanol derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-04-26 | — | — | US | disclosed |
| US-9051277-B2 | Phenyl(oxy/thio)alkanol derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-06-09 | — | — | US | disclosed |
| US-20140357649-A1 | Phenyl(oxy/thio)alkanol Derivatives | BAYER CROPSCIENCE AG (DE) | 2014-12-04 | — | — | US | disclosed |
| US-20110039865-A1 | Phenyl(oxy/thio)alkanol Derivatives | BAYER CROPSCIENCE AG (DE) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357649-A1 | Phenyl(oxy/thio)alkanol Derivatives | MYB, ALKBH3, OSBP | HMOX1 164/4885TAAR1 600/4885HTR2A 4134/4885 |
| US-20110039865-A1 | Phenyl(oxy/thio)alkanol Derivatives | MYB, ALKBH3, OSBP | HMOX1 164/4885TAAR1 600/4885HTR2A 4134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.